Advertisement
New Zealand markets closed
  • NZX 50

    12,478.50
    -186.50 (-1.47%)
     
  • NZD/USD

    0.6239
    -0.0003 (-0.04%)
     
  • NZD/EUR

    0.5582
    -0.0005 (-0.09%)
     
  • ALL ORDS

    8,437.20
    +20.20 (+0.24%)
     
  • ASX 200

    8,209.50
    +17.60 (+0.21%)
     
  • OIL

    71.77
    -0.18 (-0.25%)
     
  • GOLD

    2,647.10
    +32.50 (+1.24%)
     
  • NASDAQ

    19,791.49
    -48.34 (-0.24%)
     
  • FTSE

    8,229.99
    -98.73 (-1.19%)
     
  • Dow Jones

    42,063.36
    +38.17 (+0.09%)
     
  • DAX

    18,720.01
    -282.37 (-1.49%)
     
  • Hang Seng

    18,258.57
    +245.41 (+1.36%)
     
  • NIKKEI 225

    37,723.91
    +568.58 (+1.53%)
     
  • NZD/JPY

    89.7260
    +0.7580 (+0.85%)
     

Biogen Stock Slips As Alzheimer's Drug Looks Abroad For Quarterly Beat

Biogen Stock Slips As Alzheimer's Drug Looks Abroad For Quarterly Beat

Biogen stock slipped early Thursday despite a second-quarter beat that included strong of its new Alzheimer's treatment, Leqembi.